Showing results (521-530 of 2,775) with videos related to
Sort By:
Pageof 278
Orphanet Journal of Rare Diseases|January 29, 2021
[18F]FDG Positron emission tomography with whole body magnetic resonance imaging ([18F]FDG-PET/MRI) as a diagnosis tool in SchwannomatosisI Gallais Sérézal, S Ferkal, L Lerman, et al.Soins; La Revue De Reference Infirmiere|September 1, 2024
[Bridging the gap between the first year of the Health Sciences bachelor's degree and the second year at Ifsi]Sandrine Grenon, Véronique Guibert, Cynthia Engels, et al.Annales De Dermatologie Et De Venereologie|June 28, 2001
[Sarcoidosis: thalidomide treatment in ten patients]O Estines, J Revuz, P Wolkenstein, et al.The Journal of Investigative Dermatology|August 22, 2000
SCORTEN: a severity-of-illness score for toxic epidermal necrolysisS Bastuji-Garin, N Fouchard, M Bertocchi, et al.Plastic and Reconstructive Surgery|March 26, 2010
Facial aesthetic unit remodeling procedure for neurofibromatosis type 1 hemifacial hypertrophy: report on 33 consecutive adult patientsMikaël Hivelin, Pierre Wolkenstein, Christophe Lepage, et al.Dermatology (Basel, Switzerland)|December 18, 2008
Health-related quality of life in patients with neurofibromatosis type 1. A survey of 129 Italian patientsYllka Kodra, Sandra Giustini, Luigina Divona, et al.Obstetrics and Gynecology|February 20, 1998
Vulvovaginal involvement in toxic epidermal necrolysis: a retrospective study of 40 casesE Meneux, P Wolkenstein, B Haddad, et al.Frontiers in Neuroscience|June 18, 2016
Decreased Plasma Aβ in Hyperlipidemic APPSL Transgenic Mice Is Associated with BBB DysfunctionTina Löffler, Stefanie Flunkert, Magdalena Temmel, et al.Journal of the American Chemical Society|December 9, 2004
Nanosensors based on responsive polymer brushes and gold nanoparticle enhanced transmission surface plasmon resonance spectroscopyIryna Tokareva, Sergiy Minko, Janos H Fendler, et al.Journal of Molecular Neuroscience : MN|August 18, 2004
Beta-Synuclein-derived peptides with neuroprotective activity: an alternative treatment of neurodegenerative disorders?Manfred Windisch, Birgit Hutter-Paier, Edith Schreiner, et al.Pageof 278